Pharmaceutical

Clinigen clears out cancer therapies in line with latest growth strategy

Following the business expansion in 2022, Clinigen announced the divestment of four of its cancer therapies.

Aug 12, 2023 - 20:00
Clinigen clears out cancer therapies in line with latest growth strategy
Following the business expansion in 2022, Clinigen announced the divestment of four of its cancer therapies.
Read the original article

Tags:

Previous Article

Oxurion unlocks $1m from Atlas for diabetic macular oedema therapy

Next Article

Sutro strengthens its immuno-oncology pipeline with two new ADCs

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Six months after launch, Bert Vogelstein’s latest blood testing startup gets acquired for $450 million

STAT+: Six months after launch, Bert Vogelstein’s lates...

Apr 27, 2023

STAT+: Pharmalittle: German regulator eyes Ozempic export ban amid shortages; NIH-funded clinical trials lagging pharma’s in enrollment

STAT+: Pharmalittle: German regulator eyes Ozempic expo...

Nov 15, 2023

FLU-SV-mRNA by Curevac for Influenza A Virus, H1N1 Subt...

Dec 20, 2023